Analyze Your Search


  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Acute Coronary Syndromes
  Follow Topic   Edit Search

Acute Coronary Syndromes (ACS) represent a group of specific clinical conditions resulting from myocardial ischemia or myocardial infarction (MI) related most often to atherothrombotic coronary obstruction. For practical purposes, ACS can be divided into ST-segment elevation ACS (STE-ACS, or more commonly, ST-segment elevation MI [STEMI]) and non-ST-segment elevation ACS (NSTE-ACS), which includes both non-ST-segment elevation MI (NSTEMI) and unstable angina (UA). Notably, the clinical presentation and symptoms may be similar for these syndromes. From The Washington Manual of Cardiology Subspecialty Consult.

Your search returned 14 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
Lancet (London, England) 
... inhibition with prasugrel or ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous coronary intervention (PCI... investigator-initiated, randomised, open-label, assessor-blinded, multicentre trial (TROPICAL-ACS) done at 33 sites in Europe, patients were enrolled if they had biomarker-positive acute coronary syndrome with successful PCI and a planned duration of dual antiplatelet ...
Cardiovascular Diseases (6)
Acute Coronary Syndrome (4), Myocardial Infarction (2), more mentions
Abstract: Background -ST-segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI) management has evolved considerably over the past 2 decades ... Mortality still decreased after 2010 in patients with STEMI without reperfusion therapy, whereas no further mortality gain was found in patients with STEMI with reperfusion therapy or in patients with NSTEMI, whether or not they were treated with percutaneous coronary intervention ... Over the past 20 years, 6-month mortality after acute myocardial infarction has decreased considerably for patients with STEMI and NSTEMI.
Cardiovascular Diseases (1), Endocrine Disorders (1), Anti-Obesity and Weight Loss (1)
Myocardial Infarction (8), Hypertension (1), Obesity (1), more mentions
The New England journal of medicine 
... clinical trial, we enrolled patients with either ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) who were undergoing PCI and receiving treatment with a potent ... Results A total of 6006 patients (3005 with STEMI and 3001 with NSTEMI) were enrolled in the trial... The results were consistent between patients with STEMI and those with NSTEMI and across other major subgroups.
Myocardial Infarction (7), Thrombosis (1), more mentions
... cannot be offered to all patients with ST-segment-elevation myocardial infarction (STEMI... Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction) was an investigator-initiated, prospective, multicenter, randomized, noninferiority trial comparing ... strategy with half-dose alteplase versus PPCI in patients with STEMI 18 to 75 years of age presenting ≤6 hours after ...
Myocardial Infarction (10), Intracranial Hemorrhages (1), Heart Failure (1), more mentions
Heart (British Cardiac Society) 
AbstractText: We aimed to evaluate the limit of detection of high-sensitivity troponin (hs-cTn) and Thrombolysis In Myocardial Infarction (TIMI) score combination rule-out strategy suggested within the 2016 National Institute for Health and Care Excellence (NICE) Chest Pain of Recent Onset guidelines and ... 21109279 Keyword: acute coronary syndrome.
Cardiovascular Diseases (1)
Myocardial Infarction (1), Acute Coronary Syndrome (1), more mentions
European heart journal 
Keyword: Acute coronary syndromes. Keyword: Acute myocardial infarction. Keyword: Antithrombotic therapy. Keyword: Antithrombotics. Keyword: Emergency medical system. Keyword: Evidence. Keyword: Fibrinolysis. Keyword: Guidelines. Keyword: Ischaemic heart disease. Keyword: MINOCA. Keyword: Primary percutaneous coronary intervention. Keyword: Quality indicators. Keyword: Reperfusion therapy. Keyword: Risk assessment. Keyword: ST-segment elevation. Keyword: Secondary prevention.
Cardiovascular Diseases (1)
Myocardial Infarction (3), Heart Diseases (1), more mentions
The primary endpoint was all-cause death, myocardial infarction or unstable angina hospitalization over a median follow-up of 26.1 months... Overall discriminatory ability in predicting the primary endpoint of mortality, nonfatal myocardial infarction, and unstable angina hospitalization was similar and fair for both CAC and FT (c-statistic, 0.67 ...
Myocardial Infarction (2), Unstable Angina (2), Ischemia (1), more mentions
The New England journal of medicine 
... antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 ... The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death... and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83 ...
Muscular and Skeletal Diseases (2), Cardiovascular Diseases (2)
Myocardial Infarction (2), Cardiovascular Diseases (1), Unstable Angina (1), more mentions
Journal of the American College of Cardiology 
In addition, further evidence on the types of patients most likely to benefit from the use of ezetimibe in addition to statin therapy after acute coronary syndrome has been published. Based on results from these important analyses, the ECDP writing committee judged that it would be desirable to provide a focused update to help guide clinicians more clearly on decision ...
Cardiovascular Diseases (8), Endocrine Disorders (1), Blood Disorders and Hematology (1)
Cardiovascular Diseases (2), Hyperlipoproteinemia Type II (1), Dyslipidemias (1), more mentions
Lancet (London, England) 
... concentration at 4 weeks and subsequent cardiovascular outcomes (primary endpoint was the composite of cardiovascular death, myocardial infarction, stroke, coronary revascularisation, or unstable angina; key secondary endpoint was the composite of cardiovascular death, myocardial infarction, or stroke) and ten prespecified safety events of interest was examined over a median of 2 ...
Cardiovascular Diseases (4)
Myocardial Infarction (2), Cardiovascular Diseases (2), Unstable Angina (1), more mentions
The Canadian journal of cardiology 
... and collected data on age, sex, initial rhythm, ST-elevation myocardial infarction (STEMI) on presenting electrocardiogram (ECG), in-hospital revascularization, neurologic status (Modified ... patients were defined as having an initial shockable rhythm, no STEMI on presenting ECG, no revascularization, and good neurologic status (MRS ... Not likely ICD-eligible" patients were defined as having a STEMI on presenting ECG, revascularization, or poor neurologic status (MRS 4 ...
Heart Arrest (4), Myocardial Infarction (1), more mentions
Circulation research 
We specifically review the management of acute cardiovascular diseases, including acute coronary syndromes and stroke; the care of cardiovascular disease in the ambulatory setting, including medical strategies for vascular disease, atrial fibrillation, and heart failure; surgical strategies for arterial revascularization, rheumatic and other valvular heart disease, and ... Keyword: myocardial infarction.
Cardiovascular Diseases (15), Endocrine Disorders (1)
Cardiovascular Diseases (10), Atrial Fibrillation (2), Bradycardia (1), more mentions
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 
Patients who undergo stenting for an acute coronary syndrome benefit from DAPT for at least 12 months, but a Bayesian network meta-analysis confirms that extending DAPT beyond 12 months confers a trade-off between reduced ischaemic events and increased bleeding. However, the network meta-analysis finds no credible increase in all-cause mortality if DAPT is lengthened from three ...
Cardiovascular Diseases (2)
Heart Diseases (1), Acute Coronary Syndrome (1), more mentions
Environmental health perspectives 
... and respiratory mortality from the American Cancer Society Cancer Prevention Study II (ACS CPS-II) cohort have been used to estimate global O3-attributable mortality ... exposure in adults ≥30y of age using updated effect estimates from the ACS CPS-II cohort AbstractText: We used GEOS-Chem simulations (2×2.5º grid ...
Oncology (2)
Neoplasms (2), more mentions